Teva, Zydus Drop Some Claims In Coreg Patent Suit
By Julie Zeveloff ( November 17, 2008, 12:00 AM EST) -- Teva Pharmaceutical Industries Ltd. has agreed to drop two patents from an infringement suit against rivals Zydus Pharmaceuticals Inc. and Cadila Healthcare Ltd. over a patented process for making the key ingredient in the congestive heart treatment Coreg, but Zydus' invalidity and antitrust-related counterclaims for one of those patents remain in play....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.